Lyxor Merger Arbitrage UCITS

Presentation

NAV : 106.86 $ on 2021-09-23

Source: Lutetia Capital. The figures relating to past periods are not a reliable indicator of future results.

Characteristics

Currency: Dollar US

Approval Number: C142213

Valuation: Weekly

Custodian: Société Générale

Auditor: PWC Ireland

Recommended Investment Period: > 3 years

SRRI Lower risk, Lower potential yield Higher risk, Higher potentiel yield 1 2 3 4 5 6 7: 6 / 7

Fund Manager: Lyxor International
Asset Management SAS

Date of 1st NAV: 2015-07-06

Legal Form: Sub fund of an ICVC

Subscription

Cut-Off: 14:00(CET)

Liquidity: Weekly(Tuesday)

Lyxor Merger Arbitrage is only investable via the SGI Merger Arbitrage II Index.
The SGI Merger Arbitrage II Index offers a x2 leverage of the Lyxor Merger Arbitrage UCITS portfolio.

Lyxor Merger Arbitrage is a sub-fund of the Irish ICVC Lyxor Newcits IRL II plc, an umbrella fund with segregated liability between sub-funds authorized by the Central Bank in Ireland and managed by Lyxor International Asset Management.
For all inquiries, please contact:
Lyxor International Asset Management S.A.S
17, cours Valmy
Puteaux 92800
France
Tel. +33 8 10868788
www.lyxor.com

Documents

Performances

Description

Lyxor Merger Arbitrage is a Sub-Fund of an ICVC registered in Ireland.

The Sub-Fund seeks to deliver an absolute return uncorrelated from the markets over a recommended investment horizon of three years, by implementing a merger arbitrage strategy.

This fund is run pari passu with the historical merger arbitrage portfolio in UCITS.

Strategy

The merger arbitrage strategy of the Sub-Fund is to invest primarily in North American and European stocks subject to definitive takeover bids.

The investment process combines proprietary quantitative models and fundamental analyses, with a strong focus on risk allocation and liquidity analysis.

The portfolio is generally comprised of 30 to 50 arbitrage situations, primarily in medium-to-large cap securities.

The information presented above is not contractually binding and does not constitute investment advice. The figures relating to past periods are not a reliable indicator of future results. Management fees are included in performances. This product is not capital-guaranteed. Access to the products and services presented herein may be restricted for some individuals or countries. Taxation depends on the situation of the individual and may evolve later. The risks, fees and recommended investment period for the UCIs presented are detailed in the KIIDs (key investor information documents) and prospectuses available on this website. The KIID must be made available to the subscriber prior to purchase.

funds

index

funds

index

Lyxor Merger Arbitrage UCITS